Hinge Health Inc. (NYSE:HNGE – Get Free Report) shares rose 4.3% during mid-day trading on Monday. The company traded as high as $118.50 and last traded at $120.3760. 87,959 shares changed hands during mid-day trading, a decline of 95% from the average daily volume of 1,629,886 shares. The stock had previously closed at $115.39.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the stock. Canaccord Genuity Group boosted their price objective on shares of Hinge Health from $105.00 to $134.00 and gave the company a “buy” rating in a research report on Tuesday, November 3rd. Needham & Company LLC raised their target price on Hinge Health from $115.00 to $135.00 and gave the stock a “buy” rating in a report on Tuesday, November 3rd. Royal Bank Of Canada lifted their target price on Hinge Health from $110.00 to $135.00 and gave the company an “outperform” rating in a research report on Tuesday, November 3rd. Stifel Nicolaus boosted their price target on Hinge Health from $130.00 to $135.00 and gave the company a “buy” rating in a report on Tuesday, November 3rd. Finally, Truist Financial upped their price target on Hinge Health from $112.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, November 3rd. Two investment analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, Hinge Health currently has a consensus rating of “Buy” and an average target price of $118.93.
Check Out Our Latest Analysis on HNGE
Hinge Health Price Performance
The firm has a market capitalization of $9.86 billion, a PE ratio of 61.73, a P/E/G ratio of 1.63 and a beta of 1.19. The company has a 50-day moving average price of $103.82 and a 200 day moving average price of $70.81.
Hinge Health (NYSE:HNGE – Get Free Report) last released its earnings results on Monday, November 2nd. The company reported $0.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.44. The firm had revenue of $234.97 million during the quarter. Hinge Health had a return on equity of 66.96% and a net margin of 21.02%. The business’s revenue for the quarter was up 52.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted ($0.02) EPS. As a group, research analysts anticipate that Hinge Health Inc. will post 1.56 earnings per share for the current year.
Insiders Place Their Bets
In other Hinge Health news, Chairman Gabriel Mecklenburg sold 250,000 shares of the company’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $88.97, for a total value of $22,242,500.00. Following the completion of the transaction, the chairman directly owned 250,000 shares in the company, valued at $22,242,500. This represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Daniel Perez sold 150,000 shares of the stock in a transaction that occurred on Thursday, September 10th. The shares were sold at an average price of $89.44, for a total transaction of $13,416,000.00. Following the sale, the chief executive officer directly owned 35,470 shares of the company’s stock, valued at approximately $3,172,436.80. This trade represents a 80.88% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last quarter, insiders have sold 1,260,488 shares of company stock valued at $124,481,770. 18.92% of the stock is owned by company insiders.
Hedge Funds Weigh In On Hinge Health
Several institutional investors have recently bought and sold shares of HNGE. SBI Securities Co. Ltd. boosted its stake in shares of Hinge Health by 39.5% in the third quarter. SBI Securities Co. Ltd. now owns 364 shares of the company’s stock worth $35,000 after buying an additional 103 shares during the last quarter. ProShare Advisors LLC raised its position in Hinge Health by 2.1% during the third quarter. ProShare Advisors LLC now owns 5,588 shares of the company’s stock valued at $543,000 after acquiring an additional 117 shares in the last quarter. IFP Advisors Inc raised its position in Hinge Health by 140.0% during the second quarter. IFP Advisors Inc now owns 324 shares of the company’s stock valued at $27,000 after acquiring an additional 189 shares in the last quarter. Steward Partners Investment Advisory LLC acquired a new position in Hinge Health in the third quarter valued at approximately $26,000. Finally, Global Retirement Partners LLC lifted its holdings in Hinge Health by 9,400.0% in the third quarter. Global Retirement Partners LLC now owns 285 shares of the company’s stock valued at $28,000 after acquiring an additional 282 shares during the period.
About Hinge Health
Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company’s offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.
Further Reading
- Five stocks we like better than Hinge Health
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
- Embraer’s Record Backlog Looks Promising, But Can It Keep Its Margins Climbing?
Receive News & Ratings for Hinge Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hinge Health and related companies with MarketBeat.com's FREE daily email newsletter.
